View in EDS PDF Full Text

The effect of an abuse-deterrent opioid formulation (OxyContin) on opioid abuse-related outcomes in the postmarketing setting.

Saved in:
Bibliographic Details
Title: The effect of an abuse-deterrent opioid formulation (OxyContin) on opioid abuse-related outcomes in the postmarketing setting.
Authors: Coplan PM; Department of Risk Management and Epidemiology, Purdue Pharma L.P., Stamford, Connecticut, USA.; Adjunct, Epidemiology Department, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Chilcoat HD; Department of Risk Management and Epidemiology, Purdue Pharma L.P., Stamford, Connecticut, USA.; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Butler SF; Inflexxion Inc., Newton, Massachusetts, USA., Sellers EM; DL Global Partners Inc, Toronto, Canada.; Pharmacology and Toxicology, Medicine and Psychiatry, University of Toronto, Toronto, Canada., Kadakia A; Department of Risk Management and Epidemiology, Purdue Pharma L.P., Stamford, Connecticut, USA., Harikrishnan V; Department of Risk Management and Epidemiology, Purdue Pharma L.P., Stamford, Connecticut, USA., Haddox JD; Department of Health Policy, Purdue Pharma L.P., Stamford, Connecticut, USA.; Department of Public Health & Community Medicine, School of Medicine, Tufts University, Boston, Massachusetts, USA., Dart RC; Rocky Mountain Poison & Drug Center, Denver, Colorado, USA.; Surgery and Medicine, University of Colorado Health Sciences Center, Denver, Colorado, USA.
Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2016 Sep; Vol. 100 (3), pp. 275-86. Date of Electronic Publication: 2016 Jun 22.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 27170195
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The effect of an abuse-deterrent opioid formulation (OxyContin) on opioid abuse-related outcomes in the postmarketing setting.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Coplan+PM%22">Coplan PM</searchLink>; Department of Risk Management and Epidemiology, Purdue Pharma L.P., Stamford, Connecticut, USA.; Adjunct, Epidemiology Department, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Chilcoat+HD%22">Chilcoat HD</searchLink>; Department of Risk Management and Epidemiology, Purdue Pharma L.P., Stamford, Connecticut, USA.; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Butler+SF%22">Butler SF</searchLink>; Inflexxion Inc., Newton, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Sellers+EM%22">Sellers EM</searchLink>; DL Global Partners Inc, Toronto, Canada.; Pharmacology and Toxicology, Medicine and Psychiatry, University of Toronto, Toronto, Canada.<br /><searchLink fieldCode="AU" term="%22Kadakia+A%22">Kadakia A</searchLink>; Department of Risk Management and Epidemiology, Purdue Pharma L.P., Stamford, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Harikrishnan+V%22">Harikrishnan V</searchLink>; Department of Risk Management and Epidemiology, Purdue Pharma L.P., Stamford, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Haddox+JD%22">Haddox JD</searchLink>; Department of Health Policy, Purdue Pharma L.P., Stamford, Connecticut, USA.; Department of Public Health & Community Medicine, School of Medicine, Tufts University, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Dart+RC%22">Dart RC</searchLink>; Rocky Mountain Poison & Drug Center, Denver, Colorado, USA.; Surgery and Medicine, University of Colorado Health Sciences Center, Denver, Colorado, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220372741%22">Clinical pharmacology and therapeutics</searchLink> [Clin Pharmacol Ther] 2016 Sep; Vol. 100 (3), pp. 275-86. <i>Date of Electronic Publication: </i>2016 Jun 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372741 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-6535 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200099236%22">00099236 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacol Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27170195
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cpt.390
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 275
    Titles:
      – TitleFull: The effect of an abuse-deterrent opioid formulation (OxyContin) on opioid abuse-related outcomes in the postmarketing setting.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Coplan PM
      – PersonEntity:
          Name:
            NameFull: Chilcoat HD
      – PersonEntity:
          Name:
            NameFull: Butler SF
      – PersonEntity:
          Name:
            NameFull: Sellers EM
      – PersonEntity:
          Name:
            NameFull: Kadakia A
      – PersonEntity:
          Name:
            NameFull: Harikrishnan V
      – PersonEntity:
          Name:
            NameFull: Haddox JD
      – PersonEntity:
          Name:
            NameFull: Dart RC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2016 Sep
              Type: published
              Y: 2016
          Identifiers:
            – Type: issn-electronic
              Value: 1532-6535
          Numbering:
            – Type: volume
              Value: 100
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Clinical pharmacology and therapeutics
              Type: main
ResultId 1